79
Views
12
CrossRef citations to date
0
Altmetric
Original Research

CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients

, , , &
Pages 2909-2915 | Published online: 11 Oct 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yuxiang Han, Liling Yang, Xiaoyun Liu, Yabo Feng, Zaiying Pang & Youting Lin. (2020) HMGB1/CXCL12-Mediated Immunity and Th17 Cells Might Underlie Highly Suspected Autoimmune Epilepsy in Elderly Individuals. Neuropsychiatric Disease and Treatment 16, pages 1285-1293.
Read now
Mingyu Wei & Zuowei Duan. (2020) CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Letter]. Neuropsychiatric Disease and Treatment 16, pages 181-182.
Read now

Articles from other publishers (10)

Shan Qiao, Shan-chao Zhang, Hai-yun Li, Zhi-hao Wang, Yang Jin, Ai-hua Wang & Xue-wu Liu. (2022) Cytokines/chemokines and immune checkpoint molecules in anti-leucine-rich glioma-inactivated 1 encephalitis. Neurological Sciences 44:3, pages 1017-1029.
Crossref
Yushan Ma, Jierui Wang, Shuo Guo, Zirui Meng, Yan Ren, Yi Xie & Minjin Wang. (2023) Cytokine/chemokine levels in the CSF and serum of anti-NMDAR encephalitis: A systematic review and meta-analysis. Frontiers in Immunology 13.
Crossref
Jinyi Li, Hongyan Li, Yunhuan Wang, Xiuhe Zhao, Shengjun Wang & Ling Li. (2023) CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis. Frontiers in Immunology 13.
Crossref
Alireza Soltani Khaboushan, Mohammad-Taha Pahlevan-Fallahy, Parnian Shobeiri, Antônio L. Teixeira & Nima Rezaei. (2022) Cytokines and chemokines profile in encephalitis patients: A meta-analysis. PLOS ONE 17:9, pages e0273920.
Crossref
Nicolás Lundahl Ciano-Petersen, Sergio Muñiz-Castrillo, Cristina Birzu, Alberto Vogrig, Antonio Farina, Macarena Villagrán-García, Bastien Joubert, Dimitri Psimaras & Jérôme Honnorat. (2022) Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis. Brain Communications 4:4.
Crossref
Nabil Seery, Helmut Butzkueven, Terence J. O’Brien & Mastura Monif. (2022) Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides. Autoimmunity Reviews 21:5, pages 103074.
Crossref
Michael Levraut, Véronique Bourg, Nicolas Capet, Adrien Delourme, Jérôme Honnorat, Pierre Thomas & Christine Lebrun-Frenay. (2021) Cerebrospinal Fluid IL-17A Could Predict Acute Disease Severity in Non-NMDA-Receptor Autoimmune Encephalitis. Frontiers in Immunology 12.
Crossref
Tracie Huey‐Lin Tan, Piero Perucca, Terence J. O’Brien, Patrick Kwan & Mastura Monif. (2020) Inflammation, ictogenesis, and epileptogenesis: An exploration through human disease. Epilepsia 62:2, pages 303-324.
Crossref
Yu-Chia Kao, Ming-I Lin, Wen-Chin Weng & Wang-Tso Lee. (2020) Neuropsychiatric Disorders Due to Limbic Encephalitis: Immunologic Aspect. International Journal of Molecular Sciences 22:1, pages 389.
Crossref
Bo Sun, Melanie Ramberger, Kevin C. O’Connor, Rachael J. M. Bashford-Rogers & Sarosh R. Irani. (2020) The B cell immunobiology that underlies CNS autoantibody-mediated diseases. Nature Reviews Neurology 16:9, pages 481-492.
Crossref